Brief: Kiromic Biopharma Inc - On Dec 12, Co Amended And Restated 25% Senior Secured Convertible Promissory Note Dated October 21, 2022
16/12/2022 21:57
Dec 16 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA INC - ON DEC 12, CO AMENDED AND RESTATED
25%
SENIOR SECURED CONVERTIBLE PROMISSORY NOTE DATED OCTOBER 21,
2022
* KIROMIC BIOPHARMA INC - MATURITY RATE WAS AMENDED TO
DECEMBER
12, 2023 FROM OCTOBER 21, 2023
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site